Circular Genomics leverages circular RNA for the diagnosis and treatment of psychiatric and neurological disorders. The company is a self-described pioneer in precision medicine for mental health.

Circular Genomics

Circular Genomics is the global leader in the use of circular RNA as a novel biomarker to power precision medicine to improve the diagnosis and treatment of neurological and psychiatric conditions

Read about how we’re making precision psychiatry a reality with our novel circular RNA-based blood test that can predict patients’ responses to SSRIs. Follow us to be among the first to know when MindLight Antidepressant Response Test™ comes to market!  

#precisionpsychiatry #majordepressivedisorder #mentalhealth

The Circular Genomics team is live at Direct Primary Care Summit 2024 in Dallas! Stop by booth 31 and ask us about MindLight™, our circular RNA-based biomarker test for predicting SSRI response launching later this year. This first-of-its-kind antidepressant response test will tell healthcare providers which patients are likely to achieve clinical response to SSRIs, and not just inform them about metabolism or potential drug interactions.

#precisionpsychiatry #antidepressantresponsetest

It’s our last day at Direct Primary Care Summit in Dallas! Visit our booth #31 to learn about Circular Genomics and how we’re using circular RNA-based innovation to drive precision psychiatry. 

Follow us to be amongst the first to know when we launch our inaugural test, the MindLight™ Antidepressant Response Test™!

#precisionpsychiatry #mentalhealth

Follow our new social media pages and subscribe to our newsletter!

With so much excitement and growth, we are pleased to expand our platform to reach a variety of audiences that share our passion for improving the accuracy of diagnosis and treatment of psychiatric and neurological disorders.

Follow us on: 
Facebook at Circular Genomics
Twitter at circgenomics
Instagram at circulargenomics
 
Starting next month, Circular Genomics will be launching its newsletter, The inPsyder where we will be exploring the landscape of mental health and keeping you up to date as we bring precision psychiatry to providers and their patients. Subscribe to The inPsyder at www.circulargenomics.com
 
#CircularGenomics #PrecisionPsychiatry #PrecisionMedicine #MentalHealthInnovation

A great article by David Blivin that highlights our novel approach using circular RNAs as biomarkers for precision medicine in mental healthcare.

#mentalhealth #precisionmedicine

We’re pleased to announce that we will be exhibiting at the Direct Primary Care Summit 2024, June 21-23 in Dallas, Texas! Will you be there? If so, be sure to stop by Booth 31 to learn about Circular Genomics and our soon-to-be-launched circular RNA-based biomarker test for predicting a patient’s response to antidepressants. 

American Academy of Family Physicians American College of Osteopathic Family Physicians Family Medicine Education Consortium - FMEC
#mentalhealth #precisionpsychiatry #precisionmentalhealthcare #dpcsummit2024

Metric
Company Name	Circular Genomics
Symbol
MSH ID	COM:CIRCULARGENOMICS
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Biotechnology
Country	US
Stage
Employee Count	12
Website	circulargenomics.com
LinkedIn	circulargenomics
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:CIRCULARGENOMICS

Circular Genomics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue